Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Are human milk oligosaccharides the magic bullet for necrotizing enterocolitis?

There have been no major improvements in the prevention or treatment of necrotizing enterocolitis (NEC) over the past several decades, and therefore a 'magic bullet' is urgently needed. However, new data demonstrate that disialyllacto-N-tetraose levels in breast milk can predict the risk of NEC, and these findings might provide a strategy for successful intervention.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Proposed pathophysiology and inhibition of necrotizing enterocolitis.


  1. Frost, B. L., Modi, B. P., Jaksic, T. & Caplan, M. S. New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr. 171, 83–88 (2017).

    Article  Google Scholar 

  2. Lucas, A. & Cole, T. J. Breast milk and neonatal necrotising enterocolitis. Lancet 336, 1519–1523 (1990).

    Article  CAS  Google Scholar 

  3. Autran, C. A. et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut (2017).

  4. Moukarzel, S. & Bode, L. Human milk oligosaccharides and the preterm infant: a journey in sickness and in health. Clin. Perinatol. 44, 193–207 (2017).

    Article  Google Scholar 

  5. Sawh, S. C., Deshpande, S., Jansen, S., Reynaert, C. J. & Jones, P. M. Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ 4, e2429 (2016).

    Article  Google Scholar 

  6. Jantscher-Krenn, E. et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 61, 1417–1425 (2012).

    Article  CAS  Google Scholar 

  7. Sylvester, K. G. & Moss, R. L. Urine biomarkers for necrotizing enterocolitis. Pediatr. Surg. Int. 31, 421–429 (2015).

    Article  Google Scholar 

  8. Gordon, P. V., Swanson, J. R., MacQueen, B. C. & Christensen, R. D. A critical question for NEC researchers: can we create a consensus definition of NEC that facilitates research progress? Semin. Perinatol. 41, 7–14 (2017).

    Article  Google Scholar 

  9. Underwood, M. A. et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota. Pediatr. Res. 78, 670–677 (2015).

    Article  CAS  Google Scholar 

  10. Good, M. et al. The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br. J. Nutr. 116, 1175–1187 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Michael S. Caplan.

Ethics declarations

Competing interests

The author is a consultant for Leadiant Pharmaceuticals.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Caplan, M. Are human milk oligosaccharides the magic bullet for necrotizing enterocolitis?. Nat Rev Gastroenterol Hepatol 14, 394–395 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing